Non-Hodgkin lymphoma therapy landscape

被引：22
|
作者：
Chaudhari, Kritika [1 ]
Rizvi, Salman [2 ]
Syed, Basharut A. [2 ]
机构：
[1] Biomed Insights, Nottingham, England
[2] Rightmetrics Ltd, New York, NY 10010 USA
来源：
NATURE REVIEWS DRUG DISCOVERY | 2019年 / 18卷 / 09期
关键词：
D O I：
10.1038/d41573-019-00051-6
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：663 / 664
页数：2
相关论文
共 50 条
  • [21] Molecular pathogenesis in non-Hodgkin lymphoma: Implications for therapy
    Vose, Julie M.
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (02) : 155 - 156
  • [22] Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy
    Santo, Ana Espirito
    Medeiros, Rui
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1625 - 1634
  • [23] Therapy strategies for aggressive non-Hodgkin's lymphoma
    Held, G.
    Wulf, G.
    ONKOLOGE, 2015, 21 (10): : 946 - 952
  • [24] Rituximab therapy for indolent non-Hodgkin's lymphoma
    Hagenbeek, A
    Czuczman, MS
    Ghielmini, M
    Herold, M
    Kimby, E
    Solal-Céligny, P
    Unterhalt, M
    ANTI-CANCER DRUGS, 2002, 13 : S11 - S17
  • [25] Rituximab: An innovative therapy for non-Hodgkin's lymphoma
    Wood, AM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (03) : 215 - 229
  • [26] Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma
    Weiss, Robert F.
    Miller, Merlin G.
    Cronin, John F.
    Hensley, Harvey H.
    Joshi, Indira D.
    Smith, Mitchell R.
    PLOS ONE, 2012, 7 (12):
  • [27] Intensive therapy for non-Hodgkin lymphoma: indications and modalities
    Albin, N
    Bemba, M
    Gabarre, J
    Sutton, L
    Leblond, V
    PRESSE MEDICALE, 1998, 27 (20): : 977 - 985
  • [28] Non-Hodgkin's lymphoma after immunosuppressive therapy
    Kinlen, LJ
    GUT, 2000, 47 (04) : 462 - 463
  • [29] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
    Bei Hu
    Ryan Jacobs
    Nilanjan Ghosh
    Current Hematologic Malignancy Reports, 2018, 13 : 543 - 554
  • [30] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
    Hu, Bei
    Jacobs, Ryan
    Ghosh, Nilanjan
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 543 - 554
12345